Johnson & Johnson to Participate in the Goldman Sachs 41st Annual Global Virtual Healthcare Conference

New Brunswick, NJ (May 28, 2020) — Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 41st Annual Global Virtual Healthcare Conference on Tuesday, June 10. Jennifer Taubert, Executive Vice President, Worldwide Chairman Pharmaceuticals will represent the Company in a session scheduled at 11:20 a.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available approximately two hours after the live webcast.

  • Press Contacts:
    Cristal Downing
    (732) 524-3283
    (908) 616-8833 (M)

    Investor Contacts:
    Jennifer McIntyre
    (732) 524-3922


More:  Johnson & Johnson to Participate in the 9th Annual SVB Leerink Global Healthcare Conference

More from: | Category: Pharmaceutical Company News